Table 1 Therapeutic response criteria
Response | RECIST for HCC | mRECIST for HCC | vRECIST for HCC |
|---|---|---|---|
Complete response (CR) | Disappearance of all target lesions | Disappearance of any intra-tumoural arterial enhancement in all target lesions | Disappearance of any intra-tumoural arterial enhancement in all target lesions |
Partial response (PR) | At least 30% decrease in the diameter of the whole lesion | At least 30% decrease in the diameter of viable component measured in the arterial phase of the study | At least 65% decrease in the volume of the enhancing component measured in the arterial phase of the study |
Stable disease (SD) | Cases not fulfilling the criteria of partial response or progressive disease | ||
Progressive disease (PD) | Increase the diameters of target lesion by at least 20% | Increase the diameters of the enhancing component only by at least 20% | Increase of at least 20% in the volume of the viable (enhancing) component of the target lesions |